Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in Children with Partial Onset Seizures
NCT00236743Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jun 1994
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of topiramate in partial epilepsy, sponsored by Johnson & Johnson. Started Jun 1994; status: completed.
02
Drugs
topiramate
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT00236743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236743.